Physician profile
Lawrence E Larussa
NPI 1669812335
$7,715.60
in general payments reported to CMS, 2019-2025
8 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2021: $2,582 · 2022: $1,200 · 2024: $1,019 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,362 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,362.22 |
| Food and Beverage | $460.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $5,173.74 | 2019-2024 | |
| Treace Medical Concepts, INC. | $1,690.85 | 2024-2025 | |
| Arthrex, INC. | $455.20 | 2024 | |
| Depuy Synthes Sales INC. | $162.45 | 2024-2025 | N/A, Hammerlock2 |
| Nevro Corp. | $103.36 | 2021 | |
| Novo Nordisk INC | $78.88 | 2021 | |
| Zimmer Biomet Holdings, INC. | $34.34 | 2019 | |
| Solventum Corporation | $16.78 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Larussa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.